Download PDF
Am J Perinatol 2001; 18(6): 353-356
DOI: 10.1055/s-2001-17859
ORIGINAL ARTICLES

Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Ovarian Cyst in a Premature Infant Treated with Spironolactone

Akshaya J. Vachharajani, Jay K. Shah, Bosco A. Paes
  • The Children's Hospital at the Hamilton Health Sciences Corporation, Neonatal Division, Hamilton, Ontario, Canada
Further Information

Publication History

Publication Date:
17 October 2001 (online)

    Permissions and Reprints

ABSTRACT

We describe the late occurrence of an ovarian cyst in a premature infant, the second of a set of monochorionic diamnionic twins, during treatment with spironolactone. Spironolactone is commonly used in the management of neonatal chronic lung disease in combination with other diuretics because of its potassium-sparing effect. It has progestational activity and has been reported to cause gynecomastia. It is used widely for its antiandrogenic properties in the treatment of female hirsutism and hyperandrogenism and it has a role in the management of familial male-limited precocious puberty. However, the estrogenic influence induced during therapy may significantly alter the hormonal milieu in newborn females, resulting in the formation of ovarian cysts. Simple ovarian lesions <5 cm merit close ultrasonographic surveillance for resolution while larger complex masses may warrant surgical intervention.

KEYWORD

Ovarian cyst - spironolactone - prematurity

REFERENCES

  • 1 Schmahmann S, Haller J O. Neonatal ovarian cysts: pathogenesis, diagnosis and management.  Pediatr Radiol . 1997;  27 101-105
    CrossrefPubMedGoogle Scholar
  • 2 Muller-Leisse C, Bick U, Paulessen K. Ovarian cysts in the fetus and neonate-changes in sonographic pattern in the follow-up and their management.  Pediatr Radiol . 1992;  22 395-400
    PubMedGoogle Scholar
  • 3 Luzzatto C, Midrio P, Toffolutti T, Suma V. Neonatal ovarian cysts: management and follow-up.  Pediatr Surg Int . 2000;  16 56-59
    CrossrefPubMedGoogle Scholar
  • 4 Dolgin S E. Ovarian masses in the newborn.  Semin Pediatr Surg . 2000;  9 121-127
    CrossrefPubMedGoogle Scholar
  • 5 Lee H J, Woo S K, Kim J S, Suh S J. ``Daughter cyst'' sign: a sonographic finding of ovarian cyst in neonates,infants and young children.  Am J Roentgenol . 2000;  174 1013-1015
    CrossrefPubMedGoogle Scholar
  • 6 Barr L L, Hayden Jr K C, Stansberry S D, Swischuk L E. Enteric duplication cysts in children: are their ultrasonographic wall characteristics diagnostic?.  Pediatr Radiol . 1990;  20 326-328
    PubMedGoogle Scholar
  • 7 Zachariou Z, Roth H, Boos R, Troger J, Daum R. Three years' experience with large ovarian cysts diagnosed in utero.  J Pediatr Surg . 1989;  24 478-482
    PubMedGoogle Scholar
  • 8 Brandt M L, Luks F I, Filitrault D, Garel L, Desjardins J G, Youssef S. Surgical indications in antenatally diagnosed ovarian cysts.  J Pediatr Surg . 1991;  26 276-282
    CrossrefPubMedGoogle Scholar
  • 9 Mizuno M, Kato T, Hebiguchi T, Yoshino H. Surgical indications for neonatal ovarian cysts.  Tohoku J Exp Med . 1998;  186 27-32
    PubMedGoogle Scholar
  • 10 Esposito C, Garipoli V, Di Matteo G, De Pasquale M. Laparoscopic management of ovarian cysts in newborns.  Surg Endosc . 1998;  12 1152-1154
    CrossrefPubMedGoogle Scholar
  • 11 Sedin G, Bergquist C, Lindgren P G. Ovarian hyperstimulation syndrome in preterm infants.  Pediatr Res . 1985;  19 548-552
    CrossrefPubMedGoogle Scholar
  • 12 Shapiro G, Evron S. A novel use of spironolcatone: treatment of hirsutism.  J Clin Endocrinol Metab . 1980;  51 429-432
    PubMedGoogle Scholar
  • 13 Vetr M, Sobek A. Low dose spironolactone in the treatment of female hyperandrogenism and hirsutism.  Acta Univ Palacki Olomuc Fac Med . 1993;  135 55-57
    PubMedGoogle Scholar
  • 14 Biffignandi P, Massucchetti C, Molinatti G M. Free estradiol increase with concomitant decrease of free testosterone in plasma from normal men after incubation with spironolactone.  Horm Metab Res . 1983;  15 55-56
    PubMedGoogle Scholar
  • 15 Zgliczynski S, Baranowska B, Szymanowski J. L'influence du spironolactone sur la concentration des gonadotrophines et des hormones gonadiques dans l'hypertrophie prostatique.  J Urol (Paris) . 1981;  87 635-638
    PubMedGoogle Scholar
  • 16 Leschek E W, Jones J, Barnes K M, Hill S C, Cutler Jr B G. Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.  J Clin Endocrinol Metab . 1999;  84 175-178
    CrossrefPubMedGoogle Scholar
  • 17 Rose L I, Underwood R H, Newmark S R, Kisch E S, Williams G H. Pathophysiology of spironolactone-induced gynecomastia.  Ann Intern Med . 1977;  87 398-403
    PubMedGoogle Scholar
  • 18 Levy J, Burshell A, Marbach M, Afllalo L, Glick S M. Interaction of spironolactone with oestradiol receptors in cytosol.  J Endocrinol . 1980;  84 371-379
    PubMedGoogle Scholar
  • 19 Miyatake A, Noma K, Nakao K, Morimoto Y, Yamamura Y. Increased serum oestrone and oestradiol following spironolactone administration in hypertensive men.  Clin Endocrinol . 1978;  9 523-533
    PubMedGoogle Scholar
  • 20 Brion L P, Primhak R A, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease.  Cochrane Database Syst Rev . 2000;  3 CD001817
    PubMedGoogle Scholar
  • 21 Hoffman D J, Gerdes J S, Abbasi S. Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: a double-blind, placebo-controlled, randomized trial.  J Perinatol . 2000;  20 41-45
    Google Scholar
  • 22 Atkinson S A, Shah J K, McGee C, Steele B T. Mineral excretion in premature infants receiving various diuretic therapies.  J Pediatr . 1988;  113 540-545
    CrossrefPubMedGoogle Scholar
      >